Clinical trial · Interventional
Erector Spinae Plane Block Versus Caudal Epidural Analgesia
Role of Erector Spinae Plane Block Versus Caudal Epidural Block in Alleviating Intra- & Post-operative Pain in Pediatric Patients Undergoing Lower Limb Cancer Surgeries
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to compare the analgesic effect and safety of erector spinae plane block vs caudal epidural block in paediatric population undergoing lower limb cancer surgery. The main questions it aims to answer are: * Which of them has a superior analgesic effect. * which of them is more safe and has less complication rate. Participants or their guardians should agree to share in the study (after full explanation of risks and benefits) to receive one of the previously mentioned regional blocks in conjunction with the classic balanced general anaesthesia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Surgical Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Regional analgesia either CEA or ESP | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group of patients received Caudal Epidural Analgesia
- description
- Pediatric patients aged 8 to 15 years of age undergoing unilateral lower limb cancer surgery are recruited from National Cancer Institute \& randomly allocated to this group.
- interventionNames
- Procedure: Regional analgesia either CEA or ESP
- type
- ACTIVE_COMPARATOR
- label
- Group of patients received Erector Spinae Plane block
- description
- Pediatric patients aged 8 to 15 years of age undergoing unilateral lower limb cancer surgery are recruited from National Cancer Institute \& randomly allocated to this group.
- interventionNames
- Procedure: Regional analgesia either CEA or ESP
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 8 Years
- Maximum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * ASA ( American Society of Anaesthesiologists) II (Cancer patient receiving chemotherapy). * 8 - 15 years of age. * Planned to undergo unilateral lower limb cancer surgery. Exclusion Criteria: * Patients with coagulopathy with INR (International Normalization Ratio) \> 1.6 (e.g.: haemophilia, fibrinogen abnormalities and deficiency with concentration \< 60 %). * History of allergy to local anaesthetics or any of the additives. * Patients refused to be included in the study or their guardians. * CNS (Central Nervous System) pathology. * Unstable cardiovascular disease. * Local or systemic infection.
References
Publications (0)
Data not yet available